Please use this identifier to cite or link to this item: https://hdl.handle.net/1/2114
Title: The PRIMARY Score: Using intra-prostatic 68GA-PSMA PET/CT patterns to optimise prostate cancer diagnosis
Authors: Sheehan-Dare, Gemma ;Emmett, L.M.;Papa, N.;Buteau, J.;Ho, B.;Liu, V.;Roberts, M.;Thompson, J.;Moon, D.;Alghazo, O.;Agrawal, S.;Murphy, D.G.;Stricker, P.;Hope, T.A.;Hofman, M.
Affliation: Central Coast Local Health District
Issue Date: Mar-2022
Source: 63(11):1644-1650
Journal title: Journal of Nuclear Medicine
Department: Radiation Oncology
Abstract: Background: Multi-parametric magnetic resonance imaging (mpMRI) is validated for the diagnosis of clinically significant prostate cancer (csPCa). (68)Ga-PSMA -11 PET/CT (PSMA-PET/CT) combined with mpMRI has improved negative predictive value over mpMRI alone for csPCa. The aim of this post-hoc analysis of the PRIMARY study was to evaluate the clinical significance of patterns of intra-prostatic PSMA activity, proposing a 5- point PRIMARY score to optimise accuracy of PSMA-PET/CT for csPCa in a low prevalence population. Methods: The PRIMARY trial is a prospective multi-centre phase II imaging trial that enrolled biopsy-naïve men with suspected PCa, no prior biopsy, recent mpMRI (6 months) and planned for prostate biopsy. 291 men underwent mpMRI, PSMA-PET/CT and systematic +/- targeted biopsy. The mpMRI was read separately using PI-RADS (V2). PSMA-PET/CT (pelvic only) was acquired a minimum 60 minutes post injection. PSMA-PET/CT was centrally read for pattern (diffuse transition zone (TZ), symmetrical central zone (CZ), focal TZ or peripheral zone (PZ), and intensity (SUV(max)). In this post-hoc analysis, a 5-level PRIMARY score was assigned based on analysis of the central read: 1. No pattern, 2. Diffuse TZ or CZ (no focal), 3. Focal TZ, 4. Focal PZ or 5. SUV(max) ≥ 12. Two further readers independently assigned a PRIMARY score to 118 scans for inter-rater agreement. Associations between PRIMARY score and csPCa (ISUP≥2) were evaluated. Results: Of 291 men enrolled, 162 (56%) had csPCa. PRIMARY score-1 was present in 16% (47), score-2 in 19% (55), score-3 in 10% (29), score-4 in 40% (117) and score-5 in 15% (43). The proportion of patients with csPCa and PRIMARY score 1 to 5 was 8.5% (4/47), 27% (15/55), 38% (11/29), 76% (89/117) and 100% (43/43) respectively. Sensitivity, specificity, PPV and NPV for PRIMARY score 1,2 (low-risk patterns) vs PRIMARY score 3-5 (high-risk patterns) was 88%, 64%, 76% and 81%, compared to 83%, 53%, 69% and 72% for PI-RADS (2 vs 3-5) on mpMRI. The inter-rater agreements for PRIMARY score 1,2 vs. PRIMARY score 3-5 was 0.76 (CI: 0.64-0.88) and 0.64 (CI: 0.49-0.78). Conclusion: A PRIMARY score incorporating intra-prostatic pattern and intensity on PSMA-PET/CT shows potential with high diagnostic accuracy for csPCa. Further validation is warranted prior to implementation.
URI: https://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/2114
DOI: 10.2967/jnumed.121.263448
Pubmed: https://pubmed.ncbi.nlm.nih.gov/35301240/
ISSN: 0161-5505
Publicaton type: Journal Article
Keywords: Cancer
Radiology
Study or Trial: Multicentre Studies
Appears in Collections:Oncology / Cancer

Show full item record

Page view(s)

34
checked on Feb 5, 2023

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.